Information for "Preclinical continuing development of a manuscript CD3CD123 bispecific Tcell engager using crossover dualvariable website CODV formatting with regard to severe myeloid leukemia AML remedy"
From EECH Central
Basic information
| Display title | Preclinical continuing development of a manuscript CD3CD123 bispecific Tcell engager using crossover dualvariable website CODV formatting with regard to severe myeloid leukemia AML remedy |
| Default sort key | Preclinical continuing development of a manuscript CD3CD123 bispecific Tcell engager using crossover dualvariable website CODV formatting with regard to severe myeloid leukemia AML remedy |
| Page length (in bytes) | 3,754 |
| Page ID | 1316600 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Policemonth53 (Talk | contribs) |
| Date of page creation | 14:26, 29 March 2024 |
| Latest editor | Policemonth53 (Talk | contribs) |
| Date of latest edit | 14:26, 29 March 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
